Official websites use .gov
Secure .gov websites use HTTPS
Treating stimulant use disorder: CalAIM’s contingency management pilot
Treating stimulant use disorder: CalAIM’s contingency management pilot
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Issue brief (California HealthCare Foundation)
- Author(s):
- Hernández-Delgado, Héctor, author
- Contributor(s):
- California HealthCare Foundation, issuing body.
- Publication:
- [Oakland, California] : California Health Care Foundation, May 2022
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Amphetamine-Related Disorders -- therapy
Behavior Therapy
Pilot Projects
California - Genre(s):
- Technical Report
- Abstract:
- In the years before the COVID-19 pandemic, the United States was already seeing increasing numbers of drug overdose deaths. More than 70,000 people died of an overdose in 2019. Today, many health care providers and public officials are actively promoting evidence-based treatments to help people recover from substance misuse and substance use disorder. Medication-assisted treatment (MAT) continues to be the gold standard of care for opioid and alcohol use disorders, and states like California have made considerable progress in ensuring access to these services for Medicaid enrollees. However, the overdose epidemic in California has changed significantly in the last decade. Each year an increasing number of people die from an overdose resulting from stimulants, which include both illicit drugs, such as cocaine and methamphetamine, and prescription drugs, such as amphetamine. While there are currently no Food and Drug Administration (FDA)–approved medications to address stimulant use disorders, contingency management (CM) is a proven, effective non-medication approach. CM is a treatment service that relies on reinforcing substance use reduction and abstinence with positive rewards. California recently received authorization through a Medicaid waiver from the federal Centers for Medicare & Medicaid Services (CMS) to include CM as a Medi-Cal covered service under the California Advancing and Innovating MediCal (CalAIM) initiative. In fall 2022, California will become the first state in the nation to cover CM as a Medicaid benefit, and to evaluate its effectiveness when launched at scale in a large state.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-ND license. (More information)
- Extent:
- 1 online resource (1 PDF file (11 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 9918557473606676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918557473606676